MT Højgaard Holding A/S
18.1.2021 20:15:56 CET | Globenewswire | Press release
On 23 November 2020, MT Højgaard Holding A/S announced that a share buy-back programme of an aggregated price of up to DKK 15,000,000 was launched with the purpose to meet obligations arising from the company’s share-based incentive programme.
The share buy-back programme is executed pursuant to the so-called ”Safe Harbour” provisions in Regulation (EU) No. 596/2014 of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016. The programme will end no later than on 30 September 2021.
The following transactions have been executed from 11 January to 15 January 2021:
| Number of
shares |
Average purchase
price (DKK) |
Transaction
value (DKK) |
|
| Accumulated, last announcement | 14,820 | 159.76 | 2.367.601 |
| 11 January 2021 12 January 2021 13 January 2021 14 January 2021 15 January 2021 |
500 300 300 400 400 |
188.60 188.92 187.58 188.00 185.48 |
94,300 56,676 56,274 75,200 74,192 |
| Accumulated under the programme | 16,720 | 2,724,243 |
A detailed overview of transactions executed during the period 11 January 2021– 15 January 2021 is attached to this announcement.
Following the above transactions, MT Højgaard Holding A/S owns a total of 16,720 treasury shares, corresponding to 0.215% of the company’s total share capital.
Contact: CFO Martin Stig Solberg may be contacted by phone on +45 2270 9365
Attachments
- Appendix - Overview of transactions (11 January 2021 - 15 January 2021)
- MTHH_Company Announcement 3_2021
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Fast Ejendom Danmark29.3.2026 18:17:55 CEST | Pressemeddelelse
Aktietilbagekøbsprogram
Newcap Holdings29.3.2026 12:19:20 CEST | Pressemeddelelse
NewCap Holding A/S har indgået en aftale, betinget af underskrivelse af endelige aftaledokumenter m.v., om erhvervelse af dansk selskab indenfor compliance og risikostyringsservices – Intern viden
Novartis Pharma AG29.3.2026 07:15:00 CEST | Press release
Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%
Biogen Inc.28.3.2026 20:00:00 CET | Press release
Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
MoonLake Immunotherapeutics AG28.3.2026 20:00:00 CET | Press release
MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
